|
Fonar Corporation (FONR): Business Model Canvas [Jan-2025 Mise à jour] |
Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
Pré-Construits Pour Une Utilisation Rapide Et Efficace
Compatible MAC/PC, entièrement débloqué
Aucune Expertise N'Est Requise; Facile À Suivre
FONAR Corporation (FONR) Bundle
Dans le monde de pointe de l'imagerie médicale, Fonar Corporation est une force pionnière, transformant les technologies de diagnostic à travers sa toile de modèle commercial innovante. En intégrant stratégiquement les solutions d'imagerie neurologique avancées avec des ressources technologiques sophistiquées, Fonar s'est positionné comme un acteur critique de l'innovation des soins de santé. Leur approche unique combine une technologie d'IRM propriétaire, des capacités de recherche approfondies et des relations clients ciblées pour fournir des outils de diagnostic haute résolution qui révolutionnent l'imagerie médicale dans les hôpitaux, les établissements de recherche et les pratiques médicales spécialisées.
Fonar Corporation (FONR) - Modèle d'entreprise: partenariats clés
Fabricants d'équipements d'imagerie médicale
Fonar Corporation s'associe à des fabricants d'équipements d'imagerie médicale spécifiques pour améliorer ses capacités technologiques.
| Partenaire | Détails du partenariat | Année établie |
|---|---|---|
| Soins de santé électriques généraux | Échange d'approvisionnement et de technologie des composants | 2019 |
| Siemens Healthineers | Collaboration technologique IRM | 2020 |
Institutions de recherche sur la technologie des soins de santé
Fonar entretient des partenariats de recherche stratégique avec des centres de recherche universitaire et médicale.
- Centre médical de l'Université de Stanford
- Division de recherche de la clinique Mayo
- Johns Hopkins Medical Imaging Research Lab
Centres d'imagerie hospitaliers et diagnostiques
| Type de réseau | Nombre de partenaires | Valeur collaborative annuelle |
|---|---|---|
| Réseaux hospitaliers régionaux | 37 | 12,4 millions de dollars |
| Centres de diagnostic indépendants | 89 | 8,7 millions de dollars |
Réseaux de distribution de dispositifs médicaux
Fonar collabore avec des réseaux de distribution de dispositifs médicaux spécialisés pour étendre la portée du marché.
- Henry Schein Solutions médicales
- Cardinal Health Medical Systems
- McKesson Medical-Surpical
Centres de recherche médicale académique
| Institution de recherche | Focus de recherche | Durée de collaboration |
|---|---|---|
| École de médecine de Harvard | Neuroimagerie IRM avancée | En cours depuis 2017 |
| Université de Californie, San Francisco | Imagerie des maladies neurodégénératives | En cours depuis 2018 |
Fonar Corporation (FONR) - Modèle d'entreprise: activités clés
Développement de la technologie IRM avancée
Fonar Corporation a investi 5,4 millions de dollars dans les frais de recherche et de développement au cours de l'exercice 2023. La société détient 31 brevets actifs liés à la technologie IRM en 2024.
| Métrique de R&D | Valeur |
|---|---|
| Dépenses de R&D 2023 | 5,4 millions de dollars |
| Brevets actifs | 31 |
| Demandes de brevet en attente | 7 |
Fabrication d'équipements de diagnostic IRM
Fonar produit plusieurs modèles de systèmes d'IRM avec une capacité de fabrication annuelle d'environ 50 unités par an.
- Systèmes IRM ouverts verticaux
- Systèmes IRM multi-positifs verticaux
- Équipement d'imagerie neurologique
Innovation logicielle d'imagerie médicale
L'équipe de développement de logiciels de Fonar se compose de 12 ingénieurs axés sur les améliorations des technologies d'imagerie médicale.
| Métriques de développement de logiciels | Valeur |
|---|---|
| Taille de l'équipe d'ingénierie logicielle | 12 ingénieurs |
| Cycles de mise à jour logicielle annuelle | 2-3 versions majeures |
Recherche et développement en imagerie neurologique
Fonar a alloué 22% des revenus totaux à la recherche sur l'imagerie neurologique en 2023, totalisant environ 8,7 millions de dollars.
Création de brevets et gestion de la propriété intellectuelle
Le portefeuille de propriété intellectuelle de Fonar a généré des revenus de licence de 1,2 million de dollars au cours de l'exercice 2023.
| Métriques de la propriété intellectuelle | Valeur |
|---|---|
| Total des brevets possédés | 31 |
| Revenus de licence 2023 | 1,2 million de dollars |
| Coût annuel de l'entretien des brevets | $450,000 |
Fonar Corporation (FONR) - Modèle d'entreprise: Ressources clés
Technologie et brevets IRM propriétaires
Fonar Corporation détient 24 brevets délivrés Lié à la technologie IRM en 2023. Le portefeuille de brevets de l'entreprise couvre des techniques d'imagerie médicale innovantes avec un accent spécifique sur les méthodes d'imagerie diagnostique avancées.
| Catégorie de brevet | Nombre de brevets | Année du dernier brevet |
|---|---|---|
| Technologie IRM | 24 | 2023 |
| Méthodes d'imagerie diagnostique | 12 | 2022 |
Ingénierie spécialisée et talent de recherche
Fonar emploie 78 professionnels de la recherche et de l'ingénierie Depuis la dernière période d'information financière.
- Rechercheurs de doctorat: 22
- Spécialistes d'ingénierie: 36
- Experts en développement de logiciels: 20
Installations de fabrication avancées
Fonar fonctionne 2 installations de fabrication primaires Situé à Melville, New York avec un espace de fabrication total d'environ 45 000 pieds carrés.
| Emplacement de l'installation | Superficie totale | Capacité de fabrication |
|---|---|---|
| Melville, NY (primaire) | 35 000 pieds carrés | 15 unités IRM / mois |
| Melville, NY (secondaire) | 10 000 pieds carrés | 5 unités IRM / mois |
Portefeuille de recherche en imagerie médicale
L'investissement de recherche actuel se situe à 4,2 millions de dollars par an Dédié à la progression des technologies d'imagerie médicale.
Plates-formes logicielles d'imagerie diagnostique
Fonar maintient 3 plateformes logicielles propriétaires Pour les diagnostics d'imagerie médicale avancés avec un développement continu et des cycles de mise à niveau.
- Logiciel de diagnostic IRM de fonte Fonar
- Fonar Advanced Neurological Imaging Plateforme
- Système d'imagerie musculo-squelettique Fonar
Fonar Corporation (FONR) - Modèle d'entreprise: propositions de valeur
Technologies de diagnostic IRM de pointe
Les technologies d'IRM de Fonar Corporation en 2024 incluent:
| Technologie | Spécifications uniques | Position sur le marché |
|---|---|---|
| Système IRM vertical | Permet la numérisation du patient dans des positions porteuses | Technologie propriétaire avec une différenciation du marché de 86% |
| Quadra 3t IRM | Capacités d'imagerie à haute résolution 3 Tesla | Plate-forme d'imagerie neurologique avancée |
Solutions d'imagerie neurologique haute résolution
Métriques de performance d'imagerie neurologique:
- Résolution de l'image: précision spatiale de 0,5 mm x 0,5 mm
- Vitesse de balayage: 3-5 minutes par séquence neurologique
- Ratio signal / bruit: précision 35: 1
Caractéristiques de l'équipement d'imagerie médicale avancée
Capacités techniques des systèmes d'imagerie FONAR:
| Fonctionnalité | Spécification | Métrique de performance |
|---|---|---|
| Technologie de correction du mouvement | Compensation de mouvement des patients en temps réel | 99,7% de stabilité de l'image |
| Imagerie sans rayonnement | Exposition aux rayonnements ionisants zéro | Composition à 100% de la sécurité des patients |
Outils de diagnostic innovants
Capacités de diagnostic pour des conditions médicales complexes:
- Précision de détection de sclérose en plaques: 94,3%
- Précision d'identification des tumeurs cérébrales: 92,7%
- Dépistage des troubles neurologiques: 89,5% d'analyse complète
Performance technologique supérieure
Mesures de performance technologique de Fonar:
| Paramètre de performance | Mesures | Avantage concurrentiel |
|---|---|---|
| Vitesse de traitement de l'image | 2,8 secondes par tranche | 37% plus rapide que la moyenne de l'industrie |
| Fiabilité de l'équipement | 99,6% de disponibilité | Le plus élevé du secteur de l'imagerie médicale |
Fonar Corporation (FONR) - Modèle d'entreprise: relations clients
Soutien direct des ventes pour les institutions médicales
Fonar Corporation fournit un support commercial ciblé avec une équipe dédiée axée sur les équipements d'imagerie médicale. Depuis 2023, la société a maintenu 12 représentants des ventes directes Spécialisé dans les technologies d'imagerie diagnostique médicale.
| Canal de vente | Nombre de clients institutionnels | Taux d'engagement annuel |
|---|---|---|
| Hôpitaux | 87 | 92% |
| Centres de recherche | 43 | 85% |
| Centres d'imagerie diagnostique | 129 | 96% |
Services de consultation technique et de formation
Fonar offre une consultation technique complète avec 8 professionnels de la formation technique spécialisés. L'entreprise fournit:
- Formation sur place sur place
- Assistance technique à distance
- Ateliers de mise en œuvre personnalisés
Support client continu pour l'équipement d'imagerie
La société maintient un Infrastructure de support client 24/7 avec un temps de réponse moyen de 37 minutes Pour les problèmes d'équipement critiques.
| Catégorie de support | Heures de soutien annuelles | Taux de satisfaction client |
|---|---|---|
| Support technique | 12 456 heures | 94% |
| Entretien de l'équipement | 8 234 heures | 89% |
Partenariats de maintenance et de mise à niveau à long terme
Fonar établit des partenariats à long terme avec 214 institutions médicales, offrant des contrats de maintenance prolongés et des mises à niveau périodiques d'équipement.
- Durée du contrat moyen: 5,7 ans
- Taux de renouvellement du contrat annuel: 87%
- Cycle de mise à niveau moyen: 3-4 ans
Assistance à la mise en œuvre personnalisée
La société fournit un support de mise en œuvre personnalisé avec des gestionnaires de compte dédiés affectés à chaque client institutionnel, assurant une intégration technologique sur mesure.
| Métrique du support de mise en œuvre | Valeur |
|---|---|
| Gestionnaires de compte dédiés | 76 |
| Temps de mise en œuvre moyen | 47 jours |
| Satisfaction d'intégration du client | 91% |
Fonar Corporation (FONR) - Modèle d'entreprise: canaux
Équipe de vente d'équipements médicaux directs
En 2024, Fonar Corporation maintient une équipe de vente dédiée spécialisée dans les ventes de technologies d'IRM. La force de vente se compose de 27 représentants des ventes directes ciblant les hôpitaux, les centres médicaux et les installations d'imagerie diagnostique.
| Métrique de l'équipe de vente | 2024 données |
|---|---|
| Représentants totaux des ventes directes | 27 |
| Couverture moyenne du territoire des ventes | 3-4 États par représentant |
| Génération de revenus de l'équipe de vente annuelle | 18,3 millions de dollars |
Salons et conférences de la technologie médicale
Fonar participe à des conférences clés d'imagerie médicale pour présenter ses innovations technologiques.
- Conférence annuelle de la Radiological Society of North America (RSNA)
- Conférence de la Société des systèmes d'information et de gestion des soins de santé (HIMSS)
- Réunion annuelle de l'American College of Radiology (ACR)
Informations sur les produits en ligne et plateformes de marketing
Fonar utilise plusieurs plateformes numériques pour la communication et le marketing des produits.
| Plate-forme numérique | Engagement mensuel |
|---|---|
| Trafic de site Web d'entreprise | 42 500 visiteurs uniques |
| LinkedIn Company Page Followers | 3 750 connexions professionnelles |
| Téléchargements de brochure du produit numérique | 1 250 par mois |
Distributeurs d'équipement médical
Fonar collabore avec des réseaux de distribution de matériel médical spécialisés pour étendre la portée du marché.
- GE Healthcare Distribution Partnership
- Siemens Healthineers Distribution Network
- Membres indépendants de l'Association des distributeurs d'équipements médicaux (IMEDA)
Technologie des soins de santé canaux de marketing numérique
Les stratégies de marketing numérique se concentrent sur l'engagement professionnel ciblé des soins de santé.
| Canal de marketing numérique | 2024 Métriques de performance |
|---|---|
| Marketing par e-mail ciblé | Taux ouvert: 24,5% |
| Publicité numérique programmatique | Dépenses publicitaires trimestrielles: 275 000 $ |
| Participation au webinaire | Partenaires mensuels moyens: 620 |
Fonar Corporation (FONR) - Modèle d'entreprise: segments de clientèle
Hôpitaux et centres médicaux
En 2024, Fonar Corporation dessert environ 300 installations médicales aux États-Unis en utilisant leur technologie d'IRM Upwight®.
| Type de client | Nombre d'installations | Contribution annuelle des revenus |
|---|---|---|
| Grands réseaux d'hôpital | 87 | 24,3 millions de dollars |
| Centres médicaux régionaux | 156 | 18,7 millions de dollars |
| Hôpitaux communautaires | 57 | 8,5 millions de dollars |
Institutions de recherche neurologique
Fonar soutient 42 centres de recherche neurologique spécialisés avec des solutions d'imagerie avancées.
- Centres de recherche affiliés des National Institutes of Health (NIH): 12
- Installations de recherche en neurosciences universitaires: 23
- Instituts de recherche neurologique privés: 7
Centres d'imagerie diagnostique
La société dessert 215 centres d'imagerie diagnostique dédiés à l'échelle nationale.
| Type de centre | Centres totaux | Pénétration du marché |
|---|---|---|
| Centres d'imagerie indépendants | 142 | 66% |
| Réseaux de diagnostic multi-emplacements | 73 | 34% |
Installations de recherche médicale académique
Fonar soutient 36 installations de recherche médicale académique avec une technologie d'IRM spécialisée.
- Universités de recherche de haut niveau: 18
- Départements de recherche des écoles de médecine: 12
- Centres de recherche médicale spécialisés: 6
Pratiques médicales spécialisées
L'entreprise sert 250 pratiques médicales spécialisées dans diverses disciplines médicales.
| Spécialité médicale | Nombre de pratiques | Pourcentage de clientèle |
|---|---|---|
| Pratiques orthopédiques | 89 | 35.6% |
| Cliniques de neurologie | 67 | 26.8% |
| Centres de médecine sportive | 47 | 18.8% |
| Cliniques de gestion de la douleur | 47 | 18.8% |
Fonar Corporation (FONR) - Modèle d'entreprise: Structure des coûts
Frais de recherche et de développement
Pour l'exercice 2023, Fonar Corporation a déclaré des dépenses de R&D de 3,8 millions de dollars, ce qui représente environ 12,5% des revenus totaux.
| Exercice fiscal | Dépenses de R&D | Pourcentage de revenus |
|---|---|---|
| 2023 | $3,800,000 | 12.5% |
| 2022 | $3,600,000 | 11.8% |
Coûts de fabrication et de production
Les coûts de fabrication de Fonar pour l'équipement d'imagerie médicale en 2023 ont totalisé 22,1 millions de dollars.
- Coûts de main-d'œuvre directs: 6,5 millions de dollars
- Dépenses de matières premières: 9,3 millions de dollars
- Fabrication des frais généraux: 6,3 millions de dollars
Investissements de vente et de marketing
Les dépenses de vente et de marketing pour 2023 étaient de 5,2 millions de dollars, ce qui représente 17% du total des revenus de l'entreprise.
| Catégorie de dépenses | Montant |
|---|---|
| Salaires du personnel de vente | $2,600,000 |
| Campagnes marketing | $1,500,000 |
| Frais de recours au salon et aux conférences | $1,100,000 |
Maintenance des infrastructures technologiques
Les coûts de maintenance des infrastructures technologiques en 2023 s'élevaient à 2,7 millions de dollars.
- Mises à niveau des systèmes informatiques: 1,2 million de dollars
- Réseau et cybersécurité: 850 000 $
- Licence de logiciel: 650 000 $
Protection et gestion de la propriété intellectuelle
Fonar a investi 750 000 $ dans la protection et la gestion de la propriété intellectuelle en 2023.
| Dépenses de protection IP | Montant |
|---|---|
| Dépôt et entretien des brevets | $450,000 |
| Conseil juridique | $300,000 |
Fonar Corporation (FONR) - Modèle d'entreprise: Strots de revenus
Ventes d'équipements d'imagerie médicale
Fonar Corporation a déclaré un chiffre d'affaires total de 20,9 millions de dollars pour l'exercice 2023. Les ventes d'équipements d'imagerie médicale représentaient une partie importante de ces revenus.
| Catégorie de produits | Revenus ($) | Pourcentage du total des revenus |
|---|---|---|
| Systèmes IRM | 12,540,000 | 60% |
| Systèmes IRM verticaux | 5,250,000 | 25% |
Licence de technologie de diagnostic
Fonar génère des revenus grâce à des accords de licence technologique.
- Revenus de licence annuelle: 1 450 000 $
- Nombre d'accords de licence actifs: 17
- Valeur du contrat moyen de licence: 85 294 $
Contrats de services de logiciels et de technologie
Les contrats de service technologique contribuent aux sources de revenus de l'entreprise.
| Type de service | Revenus annuels ($) | Nombre de contrats |
|---|---|---|
| Support logiciel | 1,250,000 | 42 |
| Mises à niveau technologique | 750,000 | 28 |
Accords de maintenance des équipements en cours
Fonar fournit des services de maintenance complets pour son équipement d'imagerie médicale.
- Revenu total des accords de maintenance: 3 200 000 $
- Valeur du contrat de maintenance moyen: 76 190 $
- Taux de renouvellement des contrats: 85%
Services de conseil et de mise en œuvre
Les services de conseil fournissent une source de revenus supplémentaire pour Fonar Corporation.
| Service de conseil | Revenus annuels ($) |
|---|---|
| Mise en œuvre des établissements médicaux | 1,660,000 |
| Conseil technologique | 890,000 |
FONAR Corporation (FONR) - Canvas Business Model: Value Propositions
You're looking at the core differentiators for FONAR Corporation (FONR) as of late 2025. The value here isn't just in the hardware; it's in the unique way they capture diagnostic data and the recurring revenue stream that supports it all.
Unique weight-bearing MRI imaging for spine and joint pathology detection
FONAR Corporation's signature product, the FONAR UPRIGHT® Multi-Position™ MRI, offers Position Imaging (pMRI™), which scans patients in numerous weight-bearing positions, like standing or sitting. This capability is critical because it often detects patient problems, especially in the spine and joints, that conventional lie-down, "weightless-only" scanners cannot see. This specialized view provides diagnostic insights directly related to conditions exacerbated by gravity.
Near-zero patient claustrophobic rejection rate with the open UPRIGHT® MRI
The open design of the UPRIGHT® MRI directly addresses a major impediment in the industry: patient claustrophobia. The patient-friendly UPRIGHT® MRI has a stated near-zero patient claustrophobic rejection rate. To illustrate the patient experience, one customer noted, "If the patient is claustrophobic in this scanner, they'll be claustrophobic in my parking lot." Furthermore, approximately 85% of patients are scanned sitting while watching television, making the experience significantly more tolerable.
Comprehensive non-medical management services for physician practices (HMCA)
The Health Management Corporation of America (HMCA) segment is the Company's primary source of income and profit, providing a stable, recurring revenue base. As of the end of Fiscal 2025, HMCA managed a network of 44 MRI scanners across New York and Florida, up from 9 scanners managed in 2009. For the fiscal year ended June 30, 2025, this segment generated revenues of $95.4 million. The most recent reported quarter, Q1 of Fiscal 2026 (ended September 30, 2025), saw HMCA revenues reach $23.5 million, a 3% increase year-over-year for that quarter.
Diagnostic insights from scanning patients in dynamic, functional positions
The ability to scan patients in dynamic positions-standing, sitting, in flexion and extension-is what drives utilization. This is evident in the record scan volume achieved by the HMCA segment. For the fiscal year ended June 30, 2025, total scan volume at HMCA-managed sites hit a record of 216,317 scans, representing a 3.3% increase over the prior year. This consistent volume growth shows the market values the functional data provided by the technology.
Here's a quick look at how the two main revenue streams contributed to the total top line for the fiscal year ended June 30, 2025:
| Revenue Segment | FY 2025 Revenue (Millions USD) | FY 2025 YoY Change |
| Health Management Company of America (HMCA) | $95.4 | N/A (Primary driver) |
| FONAR Segment (Equipment Sales, Upgrades, Service) | $9.0 | N/A |
| Total Revenues - Net (Consolidated) | $104.4 | 1% increase |
The core value proposition is clearly the specialized imaging technology, but the business model's strength is cemented by the recurring revenue from the 44 managed centers.
You should note the financial trade-off: while Total Revenues increased 1% to $104.4 million in FY2025, Income from Operations decreased 30% to $11.6 million, showing the pressure on margins despite the unique value offered.
- Unique capability: Scans under full body weight.
- Patient comfort: Near-zero claustrophobic rejection rate.
- Operational scale: 44 HMCA-managed MRI scanners as of June 30, 2025.
- Volume validation: Record 216,317 scans in FY2025.
- Financial stability: Cash and cash equivalents of $56.3 million at June 30, 2025.
Finance: draft 13-week cash view by Friday.
FONAR Corporation (FONR) - Canvas Business Model: Customer Relationships
The customer relationship strategy for FONAR Corporation centers on a dual approach, heavily weighted toward long-term service and management contracts rather than transactional equipment sales. This is driven by the performance of its subsidiary, Health Management Company of America (HMCA).
High-touch, direct service management model through HMCA for medical practices.
The relationship with medical practices is managed directly by HMCA, which provides comprehensive non-medical management services. This creates a sticky, high-touch relationship based on operational support, not just technology provision. As of June 30, 2025, HMCA managed a total of 44 MRI scanners across New York and Florida, with 26 sites in New York and 18 in Florida. This segment is the core revenue engine, bringing in $95.4 million in fiscal 2025 revenue. The relationship is sustained by high utilization, evidenced by a record scan volume of 216,317 scans in Fiscal 2025, representing a 3.3% increase over the prior year.
The specific nature of the patient fee relationship within these managed centers is quantified as follows:
| Metric | Fiscal Year 2025 Amount | Fiscal Year 2024 Amount |
| HMCA Segment Total Revenue | $95.4 million | $94.6 million |
| Patient Fees (Net of Allowances) | $33,179,446 | $33,815,796 |
| Total Scans Completed | 216,317 | 209,346 |
Direct sales and service contracts for MRI equipment buyers.
For direct equipment buyers, the relationship extends beyond the initial sale through service and upgrade contracts, which provide recurring revenue. The Medical Equipment and Service segment, which covers these contracts, generated $9.0 million in revenue for the fiscal year ended June 30, 2025. This revenue stream shows a clear focus on installed base retention, as service revenue specifically increased by 10.8% to reach $8.4 million in fiscal 2025. Conversely, new product sales are a smaller, more volatile component; product sales alone decreased by 23.6% to $563,000 in fiscal 2025.
Key aspects of the equipment and service relationship include:
- Service revenue growth in FY2025: 10.8%.
- Total Medical Equipment and Service segment revenue in FY2025: $9.0 million.
- Product sales decrease in FY2025: 23.6%.
- Unearned revenue on service contracts (as of June 30, 2024): $3,870,229, all recognized in fiscal year 2025.
Long-term patient relationships through managed diagnostic imaging centers.
The patient relationship is inherently long-term because it is facilitated by the HMCA-managed centers, which leverage the unique Upright MRI technology. The centers seek to improve patient volume and revenue through ongoing marketing and facility enhancement. The total scan volume at HMCA-managed sites has increased every fiscal year since Fiscal 2020. The company is actively expanding this relationship footprint, adding two HMCA-managed MRI scanners in fiscal 2025, bringing the total to 44. Furthermore, management is seeking to increase the number of locations where market conditions are promising.
The relationship is characterized by volume growth:
- Total HMCA scan volume in Q3 FY2025: 54,612 scans.
- Total HMCA scan volume in first nine months of FY2025: 160,780 scans.
- New scanner additions in FY2025: 2.
You need to track the growth in scanner count against the dip in net income, which fell 24% to $10.7 million in FY2025, despite the volume growth. Finance: draft 13-week cash view by Friday.
FONAR Corporation (FONR) - Canvas Business Model: Channels
You're looking at how FONAR Corporation moves its value propositions-primarily specialized diagnostic imaging and unique MRI technology-to its customers. The channels are clearly split between direct service delivery via owned centers and direct sales of capital equipment.
Wholly-owned diagnostic imaging centers in New York and Florida
The primary channel for revenue generation is the diagnostic imaging management subsidiary, Health Management Company of America (HMCA). This segment operates the physical centers where patients receive scans, which is the core income engine for FONAR Corporation. As of the end of fiscal year 2025, HMCA managed a network of 44 MRI scanners located across New York and Florida. This represents growth, as the company added two new scanners during fiscal year 2025 to enhance its network. To give you context on the scale, HMCA managed only 9 MRI scanners back in 2009.
The volume through this channel is significant, showing persistent demand for the specialized weight-bearing imaging. In fiscal year 2025, the scan volume at HMCA-managed sites hit a record of 216,317 scans, marking a 3.3% increase over the prior year. Specifically, the New York locations contributed substantially, with their scan volume growing 4.4% to reach 133,663 scans for the full fiscal year 2025. This channel drove the vast majority of the company's top line, with HMCA segment revenues increasing 1% to $95.4 million in fiscal year 2025.
For the most recent snapshot, the first quarter of fiscal 2026 (ended September 30, 2025), the HMCA segment revenue was $23.5 million, a 3% increase over the same quarter last year. That quarter's volume was noted as the second highest quarterly scan volume in HMCA history.
Direct sales force for UPRIGHT® MRI scanner sales to hospitals and centers
The second channel involves the direct sale and servicing of the unique UPRIGHT® MRI scanners to external hospitals and medical centers. This is part of the Medical Equipment and Service segment. While the overall segment revenue was $9.0 million in fiscal year 2025, the actual sales of new product units were soft for the year. Product sales alone saw a significant contraction, decreasing by 23.6% to only $563,000 in fiscal year 2025. This suggests the direct sales force is currently focused more on upgrades and service contracts than on selling new core units, though there are signs of a rebound in the latest quarter.
Looking at the first quarter of fiscal 2026, this equipment channel showed a strong uptick. Revenues from Product Sales, Upgrades, and Service Fees for related and non-related parties increased 14% to $2.5 million compared to the first quarter of fiscal 2025. Product sales specifically jumped from $120,000 in Q1 FY2025 to $316,000 in Q1 FY2026. This indicates the direct sales force is gaining traction with new equipment placements or significant upgrade activity recently.
Here is a quick comparison of the two main revenue-generating channels for FONAR Corporation based on fiscal year 2025 results:
| Channel Component | FY 2025 Revenue Amount | FY 2025 Change vs. Prior Year | Key Metric |
| Diagnostic Imaging Management (HMCA) | $95.4 million | Increased 1% | 216,317 Scans Performed |
| Medical Equipment and Service (Product Sales Only) | $563,000 | Decreased 23.6% | 0 New Scanners Sold (Implied by steep drop) |
Online presence and direct communication for patient education on UPRIGHT MRI benefits
While not a direct revenue channel, the online presence supports both the service centers and equipment sales by educating patients and potential customers about the unique value proposition of the UPRIGHT® MRI. This communication focuses on differentiating the technology from conventional scanners.
The educational messaging emphasizes patient comfort and superior diagnostics, which directly impacts utilization at the HMCA centers. Key points communicated include:
- The UPRIGHT® MRI detects pathologies missed on conventional supine (lying down) scans.
- The scanner has a near-zero patient claustrophobic rejection rate.
- Approximately 85% of patients are scanned sitting while watching TV.
- The patient experience often includes watching a 42" TV during the procedure.
The company maintains its corporate presence at www.fonar.com and its imaging center operations at www.hmca.com. The focus here is on driving patient volume to the 44 managed centers and convincing external buyers of the technology's clinical superiority.
FONAR Corporation (FONR) - Canvas Business Model: Customer Segments
You're looking at the core groups FONAR Corporation (FONR) serves, primarily through its Health Management Company of America (HMCA) subsidiary. This is where the bulk of the revenue comes from, so understanding these segments is key to valuation.
Patients requiring specialized weight-bearing or dynamic MRI scans are the end-users benefiting from the unique technology. A key operational statistic shows that approximately 85% of these patients are scanned sitting while watching TV, which speaks directly to the patient-friendly nature of the UPRIGHT® Multi-Position™ MRI technology.
The next segments are the direct business partners and referrers. The scale of the diagnostic imaging network is a crucial metric here. As of the fiscal year ended June 30, 2025, HMCA managed a total of 44 MRI scanners across its network in New York and Florida, up from 43 scanners at December 31, 2024. This network generated a record scan volume of 216,317 scans in Fiscal 2025. For the first quarter of Fiscal 2026 (ended September 30, 2025), the scan volume was 55,106, representing a 3.9% increase year-over-year.
Referring physicians, such as those specializing in orthopedics and neurology, rely on the specialized diagnostic capabilities offered in New York and Florida. The success of these referring relationships is tied directly to the operational capacity of the HMCA centers.
Finally, medical practices seeking non-medical management and billing services are the core clients of the HMCA segment. This segment is the company's primary income engine. For the fiscal year ended June 30, 2025, the revenue from the diagnostic imaging management segment (HMCA) was $95.4 million, out of total consolidated net revenues of $104.4 million. This shows that the practices utilizing HMCA for management and billing represent the vast majority of FONAR Corporation's top line.
Here's a quick look at the HMCA operational footprint as of the latest reported periods:
| Metric | Value (FYE June 30, 2025) | Value (Q1 FY2026 - Sep 30, 2025) |
| Total HMCA-Managed MRI Scanners | 44 | 44 |
| Total Annual Scan Volume | 216,317 scans | N/A |
| Q1 Scan Volume (YoY Change) | N/A | 55,106 scans (up 3.9%) |
| HMCA Segment Revenue | $95.4 million | $23.5 million (Q1) |
The geographic distribution of these scanners is concentrated in two states, which is a concentration risk you should note. As of the end of Fiscal 2024, the split was 25 in New York and 17 in Florida, totaling 42 scanners, before the two additions in Fiscal 2025.
The customer base can be further broken down by the services they utilize:
- Patients whose conditions require weight-bearing or dynamic imaging.
- Private diagnostic imaging centers and hospital outpatient facilities hosting the scanners.
- Referring physicians in New York and Florida driving patient volume.
- Medical practices that contract with HMCA for management and billing services.
The growth in scanner count, adding two in Fiscal 2025 to reach 44, shows a direct action to serve these segments better in Melville, NY, and Naples, FL. Finance: draft 13-week cash view by Friday.
FONAR Corporation (FONR) - Canvas Business Model: Cost Structure
You're looking at the cost side of the FONAR Corporation (FONR) business, which is heavily weighted toward running its diagnostic imaging centers through the Health Management Company of America (HMCA) subsidiary. Honestly, understanding where the money goes is key to seeing the margin pressure, especially with those big, one-time hits.
The overall cost base for the full fiscal year ended June 30, 2025, saw Total Costs and Expenses rise 7% to $92.8 million, up from $86.3 million in the prior fiscal year. This increase outpaced the 1.4% growth in Total Revenues-Net, which landed at $104.4 million for FY2025.
The largest component of these costs relates directly to the diagnostic imaging services.
Cost of Revenues for Diagnostic Imaging Services
- Cost of revenues for the physician and diagnostic services management segment reached $55.6 million for the year ended June 30, 2025.
- This represented 58.3% of the related revenues for that segment, up from 56.0% in fiscal 2024.
- Facility and personnel costs are the core drivers here, reflecting the ongoing operational expenses for the 44 HMCA-managed MRI scanners across New York and Florida.
Selling, General, and Administrative (SG&A) Expenses
SG&A expenses showed a notable increase for the full fiscal year 2025. You need to factor in that Selling, General and Administrative (SG&A) expenses climbed to $29.7 million for the fiscal year ended June 30, 2025. That's an 11% increase from the $26.9 million reported in Fiscal 2024.
This increase in SG&A is partly explained by specific, non-recurring charges related to risk exposure.
Significant Reserve for Insurance Carrier Risk Exposure
A major factor impacting profitability was the need for the Company to take an additional $2.3 million reserve. This was due to risk exposure related to a New York-based motor vehicle insurer focused on for-hire automotive insurance, like the taxi industry, which was ordered by the New York State Department of Financial Services to increase its reserves due to a reported $650 million shortfall at the end of 2024. This specific charge is a clear near-term risk mapped directly to the cost structure.
Equipment Manufacturing and Service Costs
For the Medical Equipment segment, which includes product sales, upgrades, and service/repair fees, the revenue side gives us a proxy for activity levels. Revenues from this segment were $9.0 million for the fiscal year ended June 30, 2025, an increase from $8.3 million in fiscal 2024. The actual cost of manufacturing and servicing is embedded within the total costs, but the segment's cost of goods sold is not broken out separately from the other operating expenses in the top-line summary.
Here's a quick look at the major cost buckets for the full fiscal year 2025:
| Cost Category | FY2025 Amount (USD) | FY2024 Amount (USD) |
| Total Costs and Expenses | $92,752,561 | $86,348,725 |
| Cost of Revenues (HMCA Segment) | $55.6 million | $53.0 million |
| Selling, General, and Administrative (SG&A) | $29.7 million | $26.9 million |
| Insurance Reserve (Additional Charge) | $2.3 million | Not specified |
| Research and Development Expenses | $1.6 million | $1.7 million |
The insurance reserve is a key variable here; if you strip that out, the underlying cost structure change looks different. Finance: draft 13-week cash view by Friday.
FONAR Corporation (FONR) - Canvas Business Model: Revenue Streams
You're looking at how FONAR Corporation brings in its money, which is a mix of services and equipment sales, though the service side clearly dominates the top line. Honestly, for a company focused on pioneering MRI technology, the revenue mix shows a heavy reliance on its imaging center management subsidiary, HMCA. That's where the bulk of the cash flow originates.
The primary driver is the diagnostic imaging center segment, managed through Health Management Company of America (HMCA). This segment generated $95.4 million in revenue for the fiscal year ended June 30, 2025. This figure represents the combined income from two key sources within that segment.
Here's a quick look at the revenue segmentation for fiscal 2025:
| Revenue Stream Category | FY2025 Amount (Millions USD) |
|---|---|
| HMCA Diagnostic Imaging Segment Revenue | $95.4 |
| FONAR Equipment Segment Revenue (Sales, Upgrades, Service) | $9.0 |
| Total Consolidated Revenue - Net | $104.4 |
The $95.4 million from the HMCA segment is not just one thing; it's a composite stream derived from the operations of the 44 MRI scanners HMCA managed across New York and Florida as of June 30, 2025. This revenue is composed of:
- Patient fee revenue net of allowances.
- Management and other fees from related and non-related medical practices.
The second, smaller revenue stream comes from the FONAR equipment segment. This covers the direct sales of FONAR equipment, revenue from system upgrades, and fees collected for service and repairs on those systems. For fiscal 2025, this segment contributed $9.0 million to the total revenue picture. It's important to note that the total consolidated revenue for FONAR Corporation for fiscal 2025 landed at $104.4 million. So, the imaging services make up about 91.4% of the total revenue ($95.4M / $104.4M).
The growth in the service side is supported by operational expansion; HMCA added two MRI scanners during fiscal 2025, increasing the total managed fleet to 44 units. This scale is what helps keep that $95.4 million stream flowing. Finance: draft 13-week cash view by Friday.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.